Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomized placebo-controlled trial

BACKGROUND: Treatment-resistant major depressive disorder is common and potentially life-threatening in older persons, in whom little is known about the benefits and risks of augmentation pharmacotherapy. METHODS: We conducted a multi-site, placebo-controlled, randomized clinical trial to test the e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet
Main Authors: Lenze, Eric J., Mulsant, Benoit H., Blumberger, Daniel M., Karp, Jordan F., Newcomer, John W., Anderson, Stewart J., Dew, Mary Amanda, Butters, Meryl A., Stack, Jacqueline A., Begley, Amy E., Reynolds, Charles F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4690746/
https://ncbi.nlm.nih.gov/pubmed/26423182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(15)00308-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados